Loading...
1.1 This practice covers the production of wear debris and degradation products from implanted materials that may lead to a cascade fo biological responses resulting in damage to adjacent and remote tissues. In order to ascertain the role of particles in stimulating such responses, the nature of the responses, and the consequences of the responses, established protocols are needed. This is an emerging, rapidly developing area and the information gained from standard protocols is necessary to interpret responses and to determine if there is correlation with the in vivo responses. Since there are many possible and established ways of determining responses, a single standard protocol is not stated. However, well described protocols are needed to compare results from different investigators using the same materials and to compare biological responses for evaluating (ranking) different materials. For laboratories without established protocols, recommendations are given and indicated with an asterisk.
1.2 Since the purpose of these studies is to predict the response in humans, the use of human cells would provide much information. However in the interest of safety in laboratory protocols, the use of non-human and non-primate cells is described.
1.3 The values stated in SI units are to be regarded as the standard.
1.4 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
This practice is to be used to help assess the biocompatibility of materials used in medical devices. It is designed to test the effect of particles from the materials on macrophages. For safety reasons, the use of non human, non primate cells is recommended in this practice. For laboratories equipped and approved to work with human blood and tissue, the use of these same protocols would be advantageous for development of understanding of the interaction of cells and particles.
The appropriateness of the methods should be carefully considered by the user since not all materials or applications need be tested by this practice.
Abbreviations:
4.3.1 LPS—lipopolysaccharide (endotoxin).
4.3.2 LAL—Limulus Amebocyte Lysate.
4.3.3 ATCC—American Type Culture Collection.
4.3.4 FCS (FBS)—Fetal Calf Serum.
4.3.5 NCS—Newborn Calf Serum.
4.3.6 PBS—Phosphate Buffered Saline.
4.3.7 HANKS—A balanced salt solution.
4.3.8 MMPS—Matrix Metallo Proteases.
4.3.9 RPMI 1640—Specific Growth Medium (Roswell Park Memorial Institute).
4.3.10 HEPES—A buffering salt.
| SDO | ASTM: ASTM International |
| Document Number | F1903 |
| Publication Date | Nov. 1, 2003 |
| Language | en - English |
| Page Count | 4 |
| Revision Level | 98(2003) |
| Supercedes | |
| Committee | F04.16 |
We're glad to see you again! Please enter your email and password to continue
Need an account?
Register for an account to join our community! Gain access to exclusive content, participate in discussions, and stay updated on the latest news.
Have an account?
Forgot your password? No worries! Please enter your email to reset your password. If your email exists in our system, you will receive a password reset link.
Have an account?
We've sent an email to reset your password if an account with that email exists. Please check your inbox and follow the instructions in the email. If you don't see the email, please check your spam folder.
We have sent a verification email to you. Please check your inbox and follow the instructions in the email to verify your account. If you don't see the email, please check your spam folder.